Troy Allen Rhonemus - Net Worth and Insider Trading

Troy Allen Rhonemus Net Worth

The estimated net worth of Troy Allen Rhonemus is at least $31,236 dollars as of 2023-09-24. Troy Allen Rhonemus is the CHIEF OPERATING OFFICER of ChromaDex Corp and owns about 22,800 shares of ChromaDex Corp (CDXC) stock worth over $31,236. Details can be seen in Troy Allen Rhonemus's Latest Holdings Summary section.

Transaction Summary of Troy Allen Rhonemus


Troy Allen Rhonemus Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Troy Allen Rhonemus owns 1 companies in total, including ChromaDex Corp (CDXC) .

Click here to see the complete history of Troy Allen Rhonemus’s form 4 insider trades.

Insider Ownership Summary of Troy Allen Rhonemus

Ticker Comapny Transaction Date Type of Owner
CDXC ChromaDex Corp 2014-03-06 Chief Operating Officer

Troy Allen Rhonemus Latest Holdings Summary

Troy Allen Rhonemus currently owns a total of 1 stock. Troy Allen Rhonemus owns 22,800 shares of ChromaDex Corp (CDXC) as of June 20, 2016, with a value of $31,236.

Latest Holdings of Troy Allen Rhonemus

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CDXC ChromaDex Corp 2016-06-20 22,800 1.37 31,236

Holding Weightings of Troy Allen Rhonemus

Troy Allen Rhonemus Form 4 Trading Tracker

According to the SEC Form 4 filings, Troy Allen Rhonemus has made a total of 0 transactions in ChromaDex Corp (CDXC) over the past 5 years. The most-recent trade in ChromaDex Corp is the acquisition of 7,800 shares on June 20, 2016, which cost Troy Allen Rhonemus around $27,066.

Insider Trading History of Troy Allen Rhonemus

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Troy Allen Rhonemus Trading Performance

GuruFocus tracks the stock performance after each of Troy Allen Rhonemus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Troy Allen Rhonemus is 4.93%. GuruFocus also compares Troy Allen Rhonemus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Troy Allen Rhonemus within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Troy Allen Rhonemus's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Troy Allen Rhonemus

Average Relative Return


Average relative return per transaction

Outperforming Transactions


1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 34.51 4.93 -7.75 26.41 10.38 11.06
Relative Return to S&P 500(%) 30.2 2.22 -16.75 9.43 -4.87 -1.29

Troy Allen Rhonemus Ownership Network

Ownership Network List of Troy Allen Rhonemus

No Data

Ownership Network Relation of Troy Allen Rhonemus

Troy Allen Rhonemus Owned Company Details

What does ChromaDex Corp do?

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.

Who are the key executives at ChromaDex Corp?

Troy Allen Rhonemus is the Chief Operating Officer of ChromaDex Corp. Other key executives at ChromaDex Corp include 10 percent owner Li Ka Shing , SVP Finance / Interim CFO Brianna Gerber , and General Counsel Lisa Hatton Harrington .

ChromaDex Corp (CDXC) Insider Trades Summary

Over the past 18 months, Troy Allen Rhonemus made no insider transaction in ChromaDex Corp (CDXC). Other recent insider transactions involving ChromaDex Corp (CDXC) include a net purchase of 1,020,037 shares made by Chau Hoi Shuen Solina Holly , a net purchase of 3,467,778 shares made by Champion River Ventures Ltd , and a net purchase of 7,000 shares made by Jaksch Frank L Jr .

In summary, during the past 3 months, insiders sold 0 shares of ChromaDex Corp (CDXC) in total and bought 3,467,778 shares, with a net purchase of 3,467,778 shares. During the past 18 months, 0 shares of ChromaDex Corp (CDXC) were sold and 4,508,815 shares were bought by its insiders, resulting in a net purchase of 4,508,815 shares.

ChromaDex Corp (CDXC)'s detailed insider trading history can be found in Insider Trading Tracker table.


ChromaDex Corp Insider Transactions

No Available Data

Troy Allen Rhonemus Mailing Address

Above is the net worth, insider trading, and ownership report for Troy Allen Rhonemus. You might contact Troy Allen Rhonemus via mailing address: 26991 Moro Azul, Mission Viejo Ca 92691.

Discussions on Troy Allen Rhonemus

No discussions yet.